5,290.00
+40(+0.76%)
Currency In KRW
Address
Academic Cooperation Building
Seoul, 03759
Korea, Republic of
Phone
82 70 7008 0114
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
54
First IPO Date
August 28, 2002
| Name | Title | Pay | Year Born |
| Jong-Won Choi | Joint Chief Executive Officer | 0 | 1967 |
| Ho-Suk Chon | Joint Chief Executive Officer | 0 | 1958 |
| Seok-Yong Choi | Chief Operating Officer and Senior Managing Director | 0 | 1962 |
| Yeong-Jin Kim | President | 0 | 1970 |
Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body. The company provides Vitabrid C12, a new-conceptual vitamin C product that delivers active vitamin C into the skin. It also develops organic-inorganic hybrid technology, a drug delivery system technology that allows the selective and effective delivery of active substances on the target area in combination with bio-friendly minerals, as well as in anticancer drug carrier technology. The company was founded in 2000 and is based in Seoul, South Korea.
